Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF APRIL 06, 2013 FBO #4151
MODIFICATION

66 -- Fluorscence Microscope

Notice Date
4/4/2013
 
Notice Type
Modification/Amendment
 
NAICS
334516 — Analytical Laboratory Instrument Manufacturing
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
 
ZIP Code
20852
 
Solicitation Number
NCI-130050-EB
 
Archive Date
4/24/2013
 
Point of Contact
Erin M. Breedlove, Phone: 2402765387, Anita Hughes, Fax: 2402765401
 
E-Mail Address
breeerin@mail.nih.gov, anhughes@mail.nih.gov
(breeerin@mail.nih.gov, anhughes@mail.nih.gov)
 
Small Business Set-Aside
N/A
 
Description
Contracting Office Address Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Dr, RM 1E144 Bethesda, MD 20892-9705, UNITED STATES. Description The National Cancer Institute (NCI) plans to procure on a sole source basis with Keyence Corp of America, 669 River Drive, Suite 403 Elmwood Park, NJ 07407 for a Fluorescence microscope. This acquisition will be processed in accordance with simplified acquisition procedures as stated in FAR Part 13.106-1(b)(1). Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. The North American Industry Classification System code is 334516 and the business size standard is 500 employees. It has been determined that there is no opportunity to acquire green products or services under this contract. NCI is currently developing new imaging modalities to study physiological responses of tumors and normal tissues to radiation and chemotherapy drugs. In order to correlate biochemical processes studied with our in vivo imaging program we must also remove and section both tumor and normal tissue for analysis by immunochemistry methods. Since imaging studies the whole tissue and not just one small part of the tissue NCI must be able to analyze by immunochemistry a large area of the tissue observed in vivo. At magnifications used by most fluorescence and light microscopes usually only small parts of tissue may be analyzed at one time and this area must be carefully stitched together for complete analysis. The Keyence microscope has integrated its microscope to collect multiple sections from a tissue and stitch them together to get a complete picture of the magnified tissue studied. In this manner multiple biochemical and molecular markers may be studied and correlated with our in vivo imaging studies. NCI has found the Keyence microscope to be unique in several ways. First, the Keyence microscope uses multiple objectives to achieve the desired image magnification for stitching images together. Second, the Keyence microscope has an enclosed imaging scanning stage which allows the unit to occupy a small space in the laboratory. This is vital as other microscopes require rooms where lights must be controlled. Finally, the Keyence microscope has been engineered to rapidly scan slides using different excitation and emission wavelengths, and stitching and overlaying these images together for a complete analysis of the tissue sections studied. The Keyence microscope has been optimized for rapid scanning for multiple wavelengths to stitch together a large number of frames for views of an entire section of tissue. It is the belief of NCI that this is a sole source requirement for Keyence Corp. This is not a solicitation for competitive quotations. However, if any interested party believes they can meet the above requirement, they may submit a statement of capabilities. All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. An original and one copy of the capability statement must be received in the NCI Office of Acquisitions on or before 11:00 AM EST on April 5, 2013. No electronic capability statements will be accepted (i.e. email or fax), an original and one copy must be sent to the NCI Office of Acquisitions at the address stated above. All questions must be in writing and can be faxed (240) 276-5401 or emailed to Erin Breedlove, Contract Specialist at breeerin@nih.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the Central Contractor Registration (CCR) www.ccr.gov and the Online Representations and Certifications Applications (ORCA), http://orca.bpn.gov. No collect calls will be accepted. Please reference solicitation number NCI-130050-EB on all correspondence.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/NCI-130050-EB/listing.html)
 
Record
SN03028875-W 20130406/130404234829-7d1c3450e6f03c7fa97ad4ce2367165d (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.